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Abstract
OBJECTIVE: To study the effects of Danhong injec-
tion (DHI) on expression of the macrophage scaven-
ger receptor 1 (MSR1) and ATP-binding cassette,
sub-family A member 1 (ABCA1) genes, which en-
code scavenger receptor-A I (SR-AI) and ATP-bind-
ing cassette transporter 1 (ABCA1), respectively, as
a potential anti-atherosclerotic mechanism.
METHODS:HumanU937 cellswere stimulatedby in-
cubation with 100 nM phorbol 12-myristate 13-ace-
tate (PMA) for 48 h. These stimulated, monocyte-like
cells were then incubated for 24 h with 50 mg/L oxi-
dized low-density lipoprotein (ox-LDL, to induce
foam cell formation), together with a liver X recep-
tor (LXR) agonist or with different DHI concentra-
tions. MSR1 and ABCA1 mRNA levels were mea-
sured by fluorescence-based quantitative PCR.
RESULTS: Compared with control cells (which re-
ceived only ox-LDL), cells treated with both ox-LDL
and 10 μmol/L LXR agonist showed lower MSR1 ex-
pression (but this effect was not statistically signifi-
cant, P>0.05) and higher ABCA1 expression (P<
0.01). Cells that received ox-LDL and 3 mL/L DHI
possessed higher MSR1 mRNA levels than the con-
trols, whereas cells treated with ox-LDL and higher
DHI concentrations (10, 30 or 60 mL/L) showed low-
er MSR1 expression levels (but the differences ob-
served between DHI concentration groups were not
statistically significant, P>0.05). ABCA1 expression in
cells treated with ox-LDL and 3, 10 or 30 mL/L DHI
was higher than in the control cells, and increased
with increasing DHI concentration (P<0.05). ABCA1
expression in cells treated with ox-LDL and the
highest DHI concentration tested (60 mL/L) was
not significantly different from that in the controls.
ABCA1 mRNA levels in cells treated with ox-LDL
and DHI were similar to, or lower than, those in
cells treated with ox-LDL and the LXR agonist.
CONCLUSION: DHI does not affect MSR1 mRNA lev-
els in ox-LDL-treated U937 cells. However, at certain
concentrations (10 and 30 mL/L), DHI significantly
increases ABCA1 mRNA levels. Therefore, the an-
ti-atherosclerotic action of DHI might be mediated
by an increased expression of ABCA1.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Coronary heart disease (CHD), one of the most com-
mon cardiovascular disorders affecting human health,
is caused by atherosclerosis. One of the early pathologi-
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cal changes associated with atherosclerosis is foam cell
formation. The proteins scavenger receptor-A I
(SR-AI, encoded by the MSR1 gene) and ATP-binding
cassette transporter 1 (ABCA1) play a crucial role in
the formation of foam cells. 1,2 Foam cell formation can
be experimentally delayed by increasing ABCA1 expres-
sion or inhibiting MSR1 expression.
Recent clinical research has shown that Danhong injec-
tion (DHI), a Traditional Chinese Medicine, can ame-
liorate CHD symptoms and prevent atherosclerosis in
patients.3-5 Nevertheless, its mechanism of action is un-
known. To shed light on the anti-atherosclerotic mech-
anism of DHI, here we tested the effect of different
DHI concentrations on the expression of MSR1 and
ABCA1 in a model of foam cells consisting of activated
U937 cells treated with oxidized low-density lipopro-
tein.
MATERIALS ANDMETHODS
Instruments, cell lines and reagents
The human mononuclear cell line U937 was provided
by the Shanghai Institute of Biochemistry and Cell Bi-
ology (Shanghai, China) and was grown in a CO2 incu-
bator (Heraeus, Hanau, Germany). In addition, we
used the following reagents: ox-LDL (Peking Union-Bi-
ology, Beijing, China), RPMI-1640 substrate (Ther-
mo-Fisher Biochemical Products, Beijing, China), fetal
calf serum (Zhejiang Tianhang Biological Technology,
Zhejiang, China), DHI (batch No. 090114, BuChang
Pharma, Heze, China), oil red O (AMRESCO, Ohio,
USA) and PCR primers (Shanghai Biological Engineer-
ing Technology, Shanghai, China).
Activation of U937 cells and DHI treatments
U937 cells were incubated in RPMI-1640 medium
supplemented with 10% fetal calf serum at 37℃ in a
5% CO2 atmosphere. For our experiments, we selected
cultures in good condition at logarithmic phase after
subculturing. Then, the medium was replaced with
fresh RPMI-1640 containing 100 nM phorbol ester
(phorbol 12-myristate 13-acetate, PMA, Sigma, Saint
Louis, USA), and the cells were incubated for 48 h. Af-
ter that, we checked for the presence of adherent cells,
disaggregated them with pancreatin and then replaced
the medium with fresh RPMI-1640 to adjust cell num-
ber to 1×106 cells/L. These cells were seeded into two
six-well plates (using 3 mL of cell suspension per well)
for each one of the following seven treatments: no treat-
ment (control); 50 mg/L ox-LDL; 50 mg/L ox-LDL
and 10 umoL/L liver X receptor (LXR) agonist
T-0901317 (Sigma, Saint Louis, USA); 50 mg/L
ox-LDL and 10 mL/L DHI; 50 mg/L ox-LDL and
30 mL/L DHI; and 50 mg/L ox-LDL and 60 mL/L
DHI. After adding the test substances (i.e. ox-LDL,
T-0901317 and/or DHI), the contents of the wells
were gently mixed with a pipette tip, and the plates
were incubated for 24 h.
Quantification of MSR1 and ABCA1 mRNA levels
After harvesting the cells and extracting total cellular
RNA with an RNA extraction kit (Fastagen Biotech,
Shanghai, China), mRNA was quantified, and cDNA
was synthesized using reverse transcriptase kit (TAKA-
RA biotechnology, Dalian, China) at 15℃ for 30 min,
followed by inactivation at 85℃ for 5 min. The result-
ing cDNA was quantitated by PCR using a fluores-
cence-based quantitative PCR kit (Fastagen biotech,
Shanghai, China). The PCR reaction included a dena-
turation step at 95℃ for 30 s, followed by 40 cycles
consisting of 95℃ for 30 s and 60℃ for 30 s. The fol-
lowing PCR primers were used: ABCA1 (primer 1),
5′-ATCAAGGGCATCGTGTATGAG-3'; ABCA1
(primer 2), 5′-AGGATTGTCACCACAGCAAAC-3′ ;
SR-AI (primer 1), 5′-TTCACAATCAACAGGAGGA-
CAC-3′; SR-AI (primer 2), 5′-TTCACAATCAACAG-
GAGGACAC-3′ ; βActin (primer 1), 5′-ATCGTGC-
GTGACATTAAGGAGAAG-3′ ; and β Actin (primer
2), 5′-AGGAAGGAAGGCTGGAAGAGTG-3′ . The
Ct values for expression levels of the target genes were
derived from the PCR amplification curve using theβ-actin housekeeping gene as an internal standard and
the 2−∆∆Ct formula to calculate relative mRNA levels.
Statistical analysis
We used SPSS 18.0 (IBM, New York, USA) for statisti-
cal analysis. The mRNA levels presented in this article
are the mean±SD unless otherwise specified. Statistical
significance was evaluated by Student's t-test and
ANOVA when appropriate, otherwise by Dunnett's T3
test. We repeated the experiments three times before
taking an average Ct, then calculated the target gene ex-
pression relative to the β-actin gene by calculating the
difference between the Ct of the target gene and the Ct
of the housekeeping gene, and we used the 2−∆∆Ct formu-
la to calculate relative expression. A probability value
P<0.05 was considered statistically significant.
RESULTS
Effect of ox-LDL on MSR1 and ABCA1 expression in
U937 cells
The expression levels for MSR1 and ABCA1 were, re-
spectively, 4.67 times and 2.8 times higher in cells
treated with 50 mg/L ox-LDL than in untreated cells
(P<0.01). Lipid granules were visible in ox-LDL-treat-
ed cells, but not in untreated controls, when dyed with
oil red O (Figure 1).
Effect of different DHI concentrations on MSR1 and
ABCA1 expression in U937 cells
We treated U937 cells with ox-LDL and T-0901317
(an LXR agonist), or with ox-LDL and different DHI
concentrations. MSR1 mRNA levels were higher in
cells treated with ox-LDL and 3 mL/L DHI, and lower
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in cells treated with ox-LDL and 10, 30 or 60 mL/L
DHI, than in cells that received only ox-LDL; howev-
er, none of these differences were statistically signifi-
cant (P>0.05, Figure 2). The effect of DHI on ABCA1
mRNA levels was concentration-dependent (Figure 3).
The differences in ABCA1 mRNA levels between cells
treated with ox-LDL and 3, 10 or 30 mL/L DHI and
cells treated only with ox-LDL were statistically signifi-
cant (P<0.05). MSR1 mRNA levels were lower in cells
treated with ox-LDL and T-0901317 than in cells treat-
ed only with ox-LDL, but this difference was not statis-
tically significant (P>0.05, Figure 2). The expression of
ABCA1 was higher in cells that received ox-LDL and
T-0901317 than in cells treated only with ox-LDL (P<
0.01, Figure 3). ABCA1 mRNA levels in cells that re-
ceived ox-LDL and different DHI concentrations were
lower than those in cells treated with ox-LDL and
T-0901317, although these differences were not statisti-
cally significant for some DHI concentrations (10 and
30 mL/L, P>0.05, Figure 3).
DISCUSSION
The pathological process that leads to atherosclerosis is
initiated by the formation of foam cells, which are
monocytes and other phagocytes that have engulfed lip-
ids. During foam cell formation, ox-LDL interacts
with monocytes, and then activates and up-regulates a
membrane protein that mediates phagocytosis of
ox-LDL. The amount of ox-LDL engulfed correlates
with the concentration of ox-LDL in the surrounding
milieu. Foam cells are formed when the accumulation
of ox-LDL exceeds the phagocyte's tolerance. ABCA1
and SR-AI are phagocyte membrane proteins that have
a role in foam cell formation, because increasing AB-
CA1 expression or decreasing SR-AI expression leads
to a delay in the formation of foam cells.1,6
DHI is extracted from the plants Salvia miltiorrhiza
and Carthami tinctorii, and is medically used for pro-
moting blood circulation to remove blood stasis, for re-
laxing tendons and for activating collateral blood ves-
sels. The main active components of DHI are tanshi-
none, Salvia miltiorrhiza acid, salvianolic acid B, car-
thamin yellow and safflower phenolic glycosides.7,8 As a
model of foam cell formation, we treated U937 macro-
phage-like cells with 50 mg/L ox-LDL for 24 h, and
observed the accumulation of lipid granules in the cells
by staining with oil red O. We found that mRNA lev-
els for both ABCA1 and MSR1 were significantly high-
er in ox-LDL-treated cells than in untreated controls.
This result is consistent with previous research.1,9
LXR plays an important role in the regulation of the
metabolism of cholesterol and fatty acids. LXR ago-
nists promote ApoA1-mediated outflow of cholesterol
in macrophages by inducing ABCA1 expression.10-13 In
our study, we compared the effects of an LXR agonist
(T-0901317) and of various DHI concentrations on
Figure 1 Detection of lipid granules inside U937 cells by
staining with oil red O
A: untreated cells; B: cells treated with 50 mg/L ox-LDL.
ox-LDL: oxidized low-density lipoprotein. Intracellular lipids
are red and cell nuclei are blue.
A
B
Figure 2 Effects of LXR agonist T-0901317 and of different
DHI concentrations on MSR1 mRNA levels in ox-LDL-treated
U937 cells
A: 50 mg/L ox-LDL; B: 50 mg/L ox-LDL and 10 µmol/L
T-0901317; C: 50 mg/L ox-LDL and 3 mL/L DHI; D: 50 mg/L
ox-LDL and 10 mL/L DHI; E: 50 mg/L ox-LDL and 30 mL/L DHI;
F: 50 mg/L ox-LDL and 60 mL/L DHI. LXR: liver X receptor;
DHI: Danhong injection; MSR1: macrophage scavenger recep-
tor 1; ox-LDL: oxidized low-density lipoprotein.
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Figure 3 Effects of LXR agonist T-0901317 and of different
DHI concentrations on ABCA1 mRNA levels in ox-LDL -treat-
ed U937 cells
A: 50 mg/L ox-LDL; B: 50 mg/L ox-LDL and 10 µmol/L
T-0901317 (P<0.01 compared with A); C: 50 mg/L ox-LDL and
3 mL/L DHI; D: 50 mg/L ox-LDL and 10 mL/L DHI (P<0.05
compared with A); E: 50 mg/L ox-LDL and 30 mL/L DHI (P<
0.05 compared with A); F: 50 mg/L ox-LDL + 60 mL/L DHI (P<
0.05 compared with B). LXR: liver X receptor; DHI: Danhong
injection; ABCA1: ATP-binding cassette, sub-family A mem-
ber 1; ox-LDL: oxidized low-density lipoprotein.
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ABCA1 and MSR1 mRNA levels in ox-LDL-treated
U937 cells. We found that 3 mL/L DHI produced an
increase in MSR1 mRNA levels in ox-LDL-treated
cells. However, MSR1 expression decreased with in-
creased DHI concentrations. Nevertheless, all these dif-
ferences in MSR1 mRNA levels were not statistically
significant (P>0.05).
In contrast, DHI induced higher ABCA1 expression in
ox-LDL-treated cells in a concentration-dependent
manner. These differences in ABCA1 expression were
statistically significant (P<0.05) except for the treat-
ment with 60 mL/L DHI. The effects of intermediate
DHI concentrations (10 and 30 mL/L) on ABCA1
mRNA levels were not significantly different from the
effect caused by the LXR agonist. In contrast, ABCA1
mRNA levels in cells treated with other DHI concen-
trations (3 and 60 mL/L) were significantly lower than
those in cells treated with the LXR agonist.
Our results indicate that DHI induces ABCA1 upregu-
lation in U937 cells. For intermediate DHI concentra-
tions (10 and 30 mL/L), the effect is comparable to
that of the LXR agonist. However, lower (3 mL/L) or
higher (60 mL/L) DHI concentrations result in lower
ABCA1 mRNA levels than those induced by the LXR
agonist. Therefore, the anti-atherosclerotic effects of
DHI might be mediated by an increase in the expres-
sion of ABCA1 in phagocytes, which would lead to
greater cholesterol outflow.
REFERENCES
1 Liu JW, Su XM, Zhi XW. Effect of ox-LDL on the expres-
sion of SR-A1 and ABCAl mRNA to U937 cells. Xi' an Ji-
ao Tong Da Xue Xiao Bao (Yi Xue Ban) 2011; 32(4):
404-406.
2 Hu YW, Tang CK. Current progress in atp-binding cas-
sette transporter Al. Sheng Wu Hua Xue Yu Sheng Wu Wu
Li Jing Zhan 2008; 35(4); 373-379.
3 Huang HB, Jiang LZ. Effect observation on Danhong in-
jection in the treatment of patients with unstable angina
pectoris. Zhong Guo Xian Dai Yao Wu Ying Yong 2009; 3
(23): 17-18.
4 Yang LJ. Effect of Danhong injection on endothelial of
the patients with acute coronary syndrome. Xian Dai
Zhong Xi Yi Jie He Za Zhi 2010; 19(1): 51-52.
5 Qiang XL. Effect of Danhong injection on hsCRP of the
patients with acute coronary syndrome. Zhong Guo Xian
Dai Yi Sheng 2009; 17(30): 148-149.
6 Vaisman BL, Lambert G, Amar M, et al. ABCA1 overex-
pression leads to hyperalphalipoproteinemia and increased
biliary cholesterol excretion in transgenic mice. J Clin In-
vest 2001; 108(2): 303-309.
7 Xiao MS. Comparision of the curative effects of Danhong
injection vs compound Danshen injection in the treat-
ment for the elderly patients with non-ST elevation acute
coronary syndrome. Shi Yong Xin Dian Xue Za Zhi 2009;
18(1): 19-21.
8 Li Q, Xiong JB, Hu YL. Effect of Danhong injection on
blood rheology of the old patients with hypertension. Shi
Yong Xin Nao Fei Xue Guan Ji Bing Za Zhi 2010; 18(3):
365-366.
9 Ou X, Dai XY, Long ZF, et al. Liver X receptor-agonist al-
leviates the degree of atherosclorosis of apoE knockout
mice through up-regulation of NPC1 gene expression. Sci
Chin Ser 2008; 38(4): 356-367.
10 Gou LP, Lu Z, Qin J. Effect of adenosine triphosphate
binding cassette transporter A1 in atherosclerosis and mod-
ulated characteristics. Zhong Guo Zu Zhi Gong Cheng
Yan Jiu Yu Lin Chuang Kang Fu 2007; 11(10):
1943-1946.
11 Tang CK, Xi SM, Yin WD. Change of ATP binding cas-
sette transporter A1 expression in diabetic minipigs. Sheng
Wu Hua Xue Yu Sheng Wu Wu Li Jing Zhan 2004; 31(6):
543-549.
12 Ashav, Bryan A L, Sean B J, et al. Control of cellular cho-
lesterol efflux by the nuclear oxysterol receptor LXRalpha.
Proc Natl Acad Sci USA 2000; 97(22): 12097-12102.
13 Rigamonti E, Helin L, Lestavrl S, et al. Liver X receptor
activation controls intracellular cholesterol trafficking and
esterification in human macrophages. Circ Res 2005; 97
(7): 682-689.
387
